Market Closed -
Nasdaq Stockholm
08:59:38 15/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
3.2
SEK
|
-1.54%
|
|
+2.56%
|
-18.88%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
60.68
|
325.9
|
144.4
|
71.02
|
64.26
|
51.93
|
-
|
-
|
Enterprise Value (EV)
1 |
58.04
|
323.4
|
141.2
|
66.3
|
65.96
|
54.4
|
50.29
|
54.13
|
P/E ratio
|
-14.1
x
|
-211
x
|
-29
x
|
-10.3
x
|
-
|
-12.5
x
|
-21.4
x
|
-25
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.53
x
|
24.4
x
|
23.4
x
|
15.2
x
|
13.2
x
|
8.66
x
|
4.5
x
|
2.73
x
|
EV / Revenue
|
9.11
x
|
24.2
x
|
22.9
x
|
14.2
x
|
13.5
x
|
9.07
x
|
4.36
x
|
2.84
x
|
EV / EBITDA
|
-17
x
|
-561
x
|
-34.1
x
|
-11.4
x
|
-
|
-14.5
x
|
-22
x
|
-25.7
x
|
EV / FCF
|
-14.6
x
|
-182
x
|
-31.8
x
|
-10.1
x
|
-
|
-15.6
x
|
-14.5
x
|
-14.4
x
|
FCF Yield
|
-6.85%
|
-0.55%
|
-3.15%
|
-9.94%
|
-
|
-6.39%
|
-6.91%
|
-6.93%
|
Price to Book
|
4.92
x
|
26.7
x
|
10.8
x
|
5.89
x
|
-
|
8.32
x
|
4.83
x
|
5.99
x
|
Nbr of stocks (in thousands)
|
1,42,824
|
1,42,824
|
1,49,324
|
1,64,257
|
1,64,257
|
1,73,382
|
-
|
-
|
Reference price
2 |
0.4248
|
2.282
|
0.9674
|
0.4324
|
0.3912
|
0.2995
|
0.2995
|
0.2995
|
Announcement Date
|
13/02/20
|
18/02/21
|
17/02/22
|
17/02/23
|
16/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6.369
|
13.34
|
6.167
|
4.667
|
4.875
|
5.996
|
11.54
|
19.06
|
EBITDA
1 |
-3.424
|
-0.577
|
-4.136
|
-5.819
|
-
|
-3.752
|
-2.288
|
-2.105
|
EBIT
1 |
-4.333
|
-1.447
|
-4.875
|
-6.504
|
-4.603
|
-4.462
|
-1.7
|
0.972
|
Operating Margin
|
-68.03%
|
-10.85%
|
-79.04%
|
-139.37%
|
-94.42%
|
-74.42%
|
-14.73%
|
5.1%
|
Earnings before Tax (EBT)
1 |
-4.337
|
-1.567
|
-4.923
|
-6.554
|
-4.761
|
-4.622
|
-1.564
|
1.155
|
Net income
1 |
-4.26
|
-1.583
|
-4.89
|
-6.546
|
-4.762
|
-4.581
|
-1.564
|
1.155
|
Net margin
|
-66.88%
|
-11.87%
|
-79.3%
|
-140.27%
|
-97.69%
|
-76.41%
|
-13.54%
|
6.06%
|
EPS
2 |
-0.0301
|
-0.0108
|
-0.0334
|
-0.0420
|
-
|
-0.0240
|
-0.0140
|
-0.0120
|
Free Cash Flow
1 |
-3.975
|
-1.776
|
-4.443
|
-6.593
|
-
|
-3.477
|
-3.477
|
-3.752
|
FCF margin
|
-62.41%
|
-13.31%
|
-72.05%
|
-141.29%
|
-
|
-57.99%
|
-30.12%
|
-19.69%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/02/20
|
18/02/21
|
17/02/22
|
17/02/23
|
16/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
2.019
|
0.4225
|
0.9302
|
1.678
|
1.586
|
1.264
|
0.859
|
1.219
|
1.516
|
0.8652
|
0.789
|
1.999
|
3.264
|
EBITDA
|
-0.9519
|
-1.678
|
-1.412
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-1.135
|
-1.842
|
-1.536
|
-
|
-2.057
|
-
|
-1.093
|
-0.8039
|
-1.32
|
-1.691
|
-1.067
|
-0.876
|
-0.502
|
Operating Margin
|
-56.23%
|
-435.99%
|
-165.08%
|
-
|
-129.69%
|
-
|
-127.28%
|
-65.93%
|
-87.02%
|
-195.38%
|
-135.23%
|
-43.82%
|
-15.38%
|
Earnings before Tax (EBT)
|
-1.151
|
-1.839
|
-1.519
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-1.159
|
-1.832
|
-1.485
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-57.41%
|
-433.66%
|
-159.64%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-0.007540
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/02/22
|
28/04/22
|
19/07/22
|
02/11/22
|
17/02/23
|
27/04/23
|
18/07/23
|
07/11/23
|
16/02/24
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
1.7
|
2.46
|
-
|
2.2
|
Net Cash position
1 |
2.63
|
2.51
|
3.22
|
4.72
|
-
|
-
|
1.65
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.6559
x
|
-
|
-1.043
x
|
Free Cash Flow
1 |
-3.97
|
-1.78
|
-4.44
|
-6.59
|
-
|
-3.48
|
-3.48
|
-3.75
|
ROE (net income / shareholders' equity)
|
-29.4%
|
-11.7%
|
-39.2%
|
-54.6%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
0.0900
|
0.0900
|
0.0900
|
0.0700
|
-
|
0.0400
|
0.0600
|
0.0500
|
Cash Flow per Share
|
-0.0300
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.09
|
0.55
|
0.6
|
0.35
|
0.07
|
0.09
|
0.09
|
0.18
|
Capex / Sales
|
1.41%
|
4.16%
|
9.77%
|
7.59%
|
1.43%
|
1.53%
|
0.8%
|
0.96%
|
Announcement Date
|
13/02/20
|
18/02/21
|
17/02/22
|
17/02/23
|
16/02/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -18.88% | 52.08M | | +31.37% | 588B | | -2.60% | 364B | | +20.83% | 326B | | +5.69% | 285B | | +14.83% | 239B | | +9.93% | 210B | | -6.95% | 200B | | +10.77% | 167B | | +0.10% | 161B |
Other Pharmaceuticals
|